Devyser Diagnostics AB (publ)

BST:OL0 Stock Report

Market Cap: €158.4m

Devyser Diagnostics Management

Management criteria checks 3/4

Devyser Diagnostics' CEO is Fredrik Dahl, appointed in Jan 2025, has a tenure of less than a year. directly owns 0.21% of the company’s shares, worth €326.84K. The average tenure of the management team and the board of directors is 2.4 years and 4.2 years respectively.

Key information

Fredrik Dahl

Chief executive officer

SEK 200.0k

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownership0.2%
Management average tenure2.4yrs
Board average tenure4.2yrs

Recent management updates

Recent updates


CEO

Fredrik Dahl (47 yo)

less than a year

Tenure

SEK 200,000

Compensation

Mr. Fredrik Dahl is CEO & Director of Devyser Diagnostics AB (publ) from January 2025. Mr. Dahl was Independent Director of Devyser Diagnostics AB (publ) from 2021 to January 2025. He is Chairperson of the...


Leadership Team

NamePositionTenureCompensationOwnership
Fredrik Dahl
CEO & Directorless than a yearSEK 200.00k0.21%
€ 326.8k
Sabina Berlin
Chief Financial Officer4.2yrsno datano data
Michael Uhlin
Chief Scientific Officer2.2yrsno datano data
Camilla Wiberg
Chief Human Resource Officer2.5yrsno datano data
Theis Kipling
Chief Commercial Officer2.8yrsno datano data
John Murad
VP & GM of Devyser US2.3yrsno datano data

2.4yrs

Average Tenure

45yo

Average Age

Experienced Management: OL0's management team is considered experienced (2.4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Fredrik Dahl
CEO & Director4.2yrsSEK 200.00k0.21%
€ 326.8k
Lars Hockenstrom
Director9.2yrsSEK 200.00kno data
Pia Magrhild Gideon
Independent Director3.5yrsSEK 200.00k0.015%
€ 23.4k
Mia Arnhult
Chairman15.2yrsSEK 300.00k24.37%
€ 38.6m
Thomas Eklund
Independent Directorless than a yearno datano data

4.2yrs

Average Tenure

57yo

Average Age

Experienced Board: OL0's board of directors are considered experienced (4.2 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/13 01:00
End of Day Share Price 2025/03/13 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Devyser Diagnostics AB (publ) is covered by 5 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Erik HultgårdCarnegie Investment Bank AB
Ludvig LundgrenNordea Markets
Filip WibergPareto Securities